Phase 2
Completed N=20
Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania
Trichotillomania
Source: ClinicalTrials.gov NCT01654523 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jul 2016
Primary outcomePrimary: Mean Change in Massachusetts General Hospital Hairpulling Scale Baseline to Post-treatment — 6.695 Units on a scale — p=<0.05
Summary
The goals of the study are to further design, develop, and test an awareness enhancement and monitoring device, which will be used in the self-awareness training and general treatment of patients with compulsive hair-pulling behaviors, or trichotillomania.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Change in Massachusetts General Hospital Hairpulling Scale Baseline to Post-treatment |
6.695 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
- Must have active hair pulling over the month prior to enrollment
- Must have noticeable hair loss
- Must experience significant distress related to Trichotillomania
- Must primarily pull from the head area
- Subjects taking medications will be included
- Must be able to read/write English
Exclusion Criteria
- Current substance use diagnosis
- Chronic neurological disorder (other than chronic tics)
- Mental retardation
- Schizophrenia and other psychotic disorders
- Bipolar I disorder
- Prominent suicidal/homicidal ideation with imminent risk
Data sourced from ClinicalTrials.gov (NCT01654523). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.